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Abstract
The proprotein convertase site-1 protease (S1P) converts latent ER-membrane bound transcription factors SREBPs and ATF6
to their active forms. SREBPs are involved in cholesterol and fatty acid homeostasis whereas ATF6 is involved in unfolded
protein response pathways (UPR). Cartilage-specific ablation of S1P in mice (S1Pcko) results in abnormal cartilage devoid of
type II collagen protein (Col II). S1Pcko mice also lack endochondral bone development. To analyze S1Pcko cartilage we
performed double-labeled immunofluorescence studies for matrix proteins that demonstrated that type IIB procollagen is
trapped inside the ER in S1Pcko chondrocytes. This retention is specific to type IIB procollagen; other cartilage proteins such
as type IIA procollagen, cartilage oligomeric matrix protein (COMP) and aggrecan are not affected. The S1Pcko cartilage thus
exhibits COMP-, aggrecan-, and type IIA procollagen-derived matrices but is characterized by the absence of a type IIB
procollagen-derived matrix. To understand the molecular reason behind S1Pcko phenotypes we performed genome-wide
transcriptional profiling of cartilage isolated from S1Pcko and wild type littermates. While the UPR pathways are unaffected,
the SREBPs-directed cholesterol and fatty acid pathways are significantly down-regulated in S1Pcko chondrocytes, with
maximal down-regulation of the stearoyl-CoA desaturase-1 (Scd1) gene. However, mouse models that lack Scd1 or exhibit
reduction in lipid homeostasis do not suffer from the ER retention of Col II or lack endochondral bone. These studies
indicate an indispensable role for S1P in type IIB procollagen trafficking from the ER. This role appears not to be related to
lipid pathways or other current known functions of S1P and is likely dependent on additional, yet unknown, S1P substrates
in chondrocytes.
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maintaining cellular homeostasis and therefore S1P plays major
and critical roles in fundamental developmental pathways.
Mutational inactivation of S1P in zebrafish (gonzo) results in
abnormal lipid metabolism and skeletal formation [6].
Mammalian skeletal development begins early during embryogenesis. It involves endochondral bone formation, a process by
which most long and axial bones of the body are formed [7].
During this process, mesenchymal cells aggregate to form
condensations and cells in the center of these condensations
differentiate to form chondrocytes [8]. Chondrocytes secrete a
specialized extracellular matrix (ECM) called cartilage that forms
the anlagen for future skeleton, whereas the surrounding
undifferentiated cells form the perichondrium [9]. The innermost
cells within the chondrocytes differentiate to form hypertrophic
chondrocytes, with cells in the inner layer of the perichondrium
differentiating into bone-forming osteoblasts resulting in a bone

Introduction
Site-1 protease (S1P; also called the membrane-bound transcription factor protease, site-1) is a proprotein convertase that
converts latent, endoplasmic reticulum (ER) membrane-bound
transcription factors into their free and active form. Two
developmental pathways regulated by S1P that have been studied
extensively include cholesterol and fatty acid homeostasis and the
unfolded protein response [1]. During cholesterol and fatty acid
homeostasis, S1P plays a fundamental role in the processing of the
transcription factors sterol regulatory element binding proteins
(SREBP-1a, -1c, and -2) [2]. During unfolded protein response
(UPR), S1P plays a critical role in the processing of activating
transcription factor 6 (ATF6) [3], old astrocyte specifically induced
substance (OASIS) [4], and the cAMP-responsive element binding
protein H (CREBH) [5]. All these pathways are fundamental in
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either 10% donkey serum or 10% goat serum. The two primary
antibodies (Table 1) were added together in 1.5% donkey serum
(or goat serum) and incubated in a humidified chamber for 1 h.
The slides were washed three times in PBS for 15 min and rinsed
once in distilled water. The two secondary antibodies were then
added together and incubated for 1 h, washed thoroughly and
mounted with Vectashield DAPI (Vector Laboratories, Inc., CA).
Antibody concentrations were as follows: antibodies to Col II triple
helical domain (THD; IIF antibody [16]), Col IIA (designed
against exon 2; IIA antibody) [15,16], aggrecan (rabbit antisera
against rat aggrecan, a gift of Dr. Kurt Doege), and cartilage
oligomeric matrix protein (COMP) [17] were used at 1:100.
Affinity-purified IIBN antibody (designed against type II collagen
exon 1–3 peptide junction and specific to type IIB procollagen)
[18] was used at 5 mg/mL, while goat anti-human calnexin
(Santacruz Biotechnology) and anti-XBP-1 (Biolegend, CA, USA)
antibodies were used at 1:50. The secondary donkey anti-goat
Alexa 488 (Invitrogen) and donkey anti-rat Alexa 594 (Invitrogen)
antibodies were all used at 1:250. Images were captured using a
60X, 1.4 NA oil immersion objective mounted on an Eclipse E800
microscope (Nikon) and QImaging Retiga 2000R Fast 1394
camera and deconvolved. For deconvolution imaging, MetaMorph software (Molecular Devices) was used to control the Zmotor device (Prior Scientific), to capture and deconvolve images,
and to compile them to give a final image. All images shown are
for mature columnar proliferative chondrocytes in the WT and for
a corresponding region in S1Pcko (Fig. S1A).

collar around the cartilaginous core [10–12]. Fully differentiated
hypertrophic cells secrete a distinct ECM which gradually
becomes calcified before they die through apoptosis. The
mineralization of the ECM allows for vascular invasion from the
bone collar and the entry of osteoclasts and osteoblasts that
degrade the mineralized cartilage to deposit endochondral bone
[13]. Deposition of a type I collagen-rich bone matrix results in
two opposing growth plates allowing for bone growth in both
directions [14]. In contrast to endochondral bone formation, much
of the craniofacial skeletal bones are formed by intramembranous
ossification where the mesenchymal cells differentiate directly into
osteoblasts without requiring a cartilage intermediate.
It follows from this developmental paradigm that factors that
affect cartilage development also impact endochondral bone
development. The link of S1P to cartilage development was
shown by the study of zebrafish gonzo mutant [6]. In a previous
study we showed that S1P is required for proper cartilage matrix
development in mice [15]. By creating cartilage-specific S1P
knockout mice (S1Pcko) we demonstrated that these mice do not
form any endochondral bone. S1Pcko mice also exhibited poor
cartilage development with most of the type II collagen protein
(Col II) trapped inside the cell, resulting in a drastic reduction of
Col II in the cartilage. Ultrastructural analysis of the cartilage
showed engorged and fragmented ER.
In the current study we investigated the nature of Col II
entrapment and the mechanistic reasons behind S1Pcko phenotypes. Lack of S1P would result in lack of activation of SREBPs,
ATF6, OASIS, and CREBH. Therefore, lack of S1P activity in
chondrocytes would be expected to affect both the SREBPsdirected cholesterol and fatty acid homoeostasis and the UPR
pathways. In order to understand how lack of S1P affects the
downstream pathways, transcriptional profiling in chondrocytes
was performed by genome-wide expression analyses with RNA
extracted from the cartilage of S1Pcko and wild type (WT)
littermates. Our studies show that the SREBPs-dependent
cholesterol and fatty acid biosynthetic pathways are downregulated in S1Pcko chondrocytes. In contrast, UPR pathways
remain unaffected. Furthermore, lack of S1P in cartilage results
specifically in the ER retention of type IIB procollagen (pro-Col
IIB). These data suggest that S1P has an indispensable function in
pro-Col IIB trafficking from the ER to the cartilage matrix.
However, our in depth mechanistic analyses indicate that this
activity is not related to current known functions of S1P.
Additional, yet unidentified, S1P substrates presumably modulate
Col II trafficking from the ER to the cartilage ECM.

Genome-wide expression profiling
To profile gene expression in S1Pcko cartilage and to contrast it
with WT, we harvested the chondroepiphyseal cartilage from the
tips of long bones in forelimbs/hindlimbs (Fig. S1B) of freshly
harvested embryonic (E) 16.5 S1Pcko (S1Pf/f;Col2-Cre) embryos
and its WT (S1Pf/f, S1Pf/+, or S1Pf/+;Col2-Cre) littermates, as the
mutant mice die during or very soon after birth. At E16.5 the
mutant is easily distinguished without genotyping, plus identifying
and separating the bones from the musculature is easier than at
later time points in the mutant. After harvesting the bones, excess
muscle tissue and blood vessels were removed by rolling on
Whatman filter paper, and the chondroepiphyseal cartilage from
the ends of the bones were broken off (Fig. S1B) and stored in
Trizol (Invitrogen) at 280uC for RNA extractions later. In some
cases the chondroepiphyseal cartilage was not separated and the
entire long bones kept intact and stored in Trizol for RNA
extraction. The calvarium was also surgically removed in some
cases and stored in Trizol at 280uC and RNA extracted as for the
chondroepiphysis. Therefore three kinds of tissue were harvested:

Materials and Methods
Ethics Statement
All mouse procedures were performed in accordance with
National Institutes of Health’s Guide for the Care and Use of
Laboratory Animals using vertebrate animals/ethics protocols
reviewed and approved by the Animal Studies Committee at
Washington University School of Medicine.

Table 1. Summary of antibodies used for
immunohistochemical analyses.

Double-labeled immunofluorescence studies
Double-labeled immunofluorescence to analyze retention of
matrix proteins in the ER were performed on 5- mm formalin
fixed, paraffin embedded sections from E16.5 embryonic tissues
processed as described [15]. Following rehydration through
graded ethanol solutions, the sections were washed in phosphate
buffered saline, pH 7.4 (PBS) for 10 min. For antigen retrieval the
slides were treated with Proteinase K (10 mg/mL in 10 mM TrisHCl pH 7.4) for 30 min at 37uC followed by blocking for 1 h in
PLOS ONE | www.plosone.org

Antibody

Protein recognized

IIF

Type II collagen triple helical domain (THD)

IIA

Type IIA procollagen (Col IIA)

IIBN

Type IIB procollagen (pro-Col IIB)

Anti-calnexin

Calnexin

Anti-XBP-1

XBP-1

Anti-aggrecan

Aggrecan

Anti-COMP

COMP

doi:10.1371/journal.pone.0105674.t001
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chondroepiphyseal cartilage from the tips of long bones, entire
long bones (includes both the bone and epiphyseal cartilage), and
calvaria.
To extract RNA, the harvested tissues were first homogenized
in Trizol using a polytron and RNA extracted according to the
manufacturer’s recommended protocol and column purified by
RNeasy mini kit (Qiagen). Genome-wide expression profiling was
performed using Illumina MouseWG-6 v1.1 Expression BeadChip
which profiles 45,200 mouse transcripts. Statistically significant
differentially expressed genes (false discovery rate (FDR) of 5%) in
S1Pcko chondrocytes as compared to WT were identified by 2-way
ANOVA (analysis of variation) analysis using Partek Genomics
Suite (St. Louis, MO). Only genes that were two-fold or more
differentially regulated with significant p-values (p,0.05) were
carried forward for characterization. Differential gene expression
data derived from microarray analysis was used to identify
functional and molecular networks through the use of MetaCore
GeneGo network building tools (GeneGo Inc., Carlsbad, CA).
Again, only genes that were two-fold or more differentially
regulated were used to generate a network score of negative log of
the p value to determine biological pathways disrupted in S1Pcko
chondrocytes. The raw microarray data have been deposited in
the Gene Expression Omnibus (GEO). The accession number is
GSE55577 (online at http://www.ncbi.nlm.nih.gov/projects/
geo).

based on size. Analysis by restriction digestion was performed as
described [22]. Briefly, the cDNA was first amplified using the
XBP-1 primers 3S and 12AS followed by digestion of the
amplified PCR product with PstI to selectively cleave the cDNA
derived from un-spliced XBP-1 mRNA, and analyzed in a 2%
agarose gel.
For a global analysis of ER stress response in S1Pcko
chondrocytes the RT2 Profiler PCR Array System for the murine
UPR (Cat. No. PAMM-089C-2, SABiosciences, Qiagen), which
profiles the expression of 84 key genes involved in recognizing and
responding to unfolded protein accumulation in the ER, was used
(a complete list of proteins profiled can be found at http://
sabiosciences.com/rt_pcr_product/HTML/PAMM-089A.html)
(also listed in Table S2). The RNA was converted to cDNA using
the RT2 First Strand kit (Cat. No. C-03) and qPCR reactions set
up using the RT2 SYBR Green/ROX qPCR master mix (Cat.
No. PA-012) in a 96-well array plate following instructions
recommended by the manufacturer. A total of four qPCR arrays
were used, two for WT and two for S1Pcko RNA for biological
duplicates. Each WT or S1Pcko RNA was pooled from the
chondroepiphyseal cartilage of two E16.5 WT or two E16.5 S1Pcko
embryos, respectively. Thus a total of four WT and four S1Pcko
E16.5 embryos were profiled. Analysis of the data was done using
the Qiagen-SABiosciences’ web-based PCR data analysis software.

Miscellaneous

Quantitative real-time PCR (qPCR) analysis

S1Pcko mice were generated by mating S1Pf/f mice with S1Pf/+;
Col2-cre mice as described [15]. Scd12/2 mice were generated
by mating Scd1+/2 heterozygotes and identified by genotyping
[23]. Scd1+/2 heterozygote parental strains and the S1Pf/f and
S1Pf/+;Col2-Cre strains were all fed ad libitum with standard
laboratory chow. Analysis of endochondral bone formation in
Scd12/2 mice by Safranin O, Fast green, and hematoxylin
staining and Col II deposition by double-labeled immunofluorescence were done as for S1Pcko mice at E15.5. In situ hybridization
analyses were done on 5- mm paraffin-embedded sections as
described previously using 35S-labeled riboprobes [15,24]. Riboprobes for the murine Scd1, Scd2, Ldlr, Fads2, and Fdps genes
were derived from their full-length cDNA clones purchased from
commercial sources. Murine Scd1 immunohistochemistry (IHC)
was performed on 5- mm paraffin-embedded sections using antiScd1 antibody (Santacruz Biotechnology) and HRP-conjugated
anti-goat IgG and DAB. Hematoxylin was used as the counter
stain. In situ hybridization images were viewed with BX51
(Olympus) microscope and images captured with a digital camera
(DP70; Olympus) using DP controller software (Olympus). Images
of hybridization signals were artificially colored red and superimposed on toluidine blue-counterstained images using Photoshop
(Adobe).

Quantitative real time PCR (qPCR) was performed for
confirmation of expression profiling for genes involved in
cholesterol and fatty acid homeostasis. For qPCR analysis, the
RNA was harvested and pooled from the chondroepiphyseal
cartilage of forelimbs and hindlimbs of five E16.5 S1Pcko and five
E16.5 WT (three S1Pf/f, one S1Pf/+, and one S1Pf/+;Col2-Cre
mice) littermates. The RNA was extracted with Trizol and column
purified as described above and used for qPCR analysis using
SYBR Green primer sets, 26 SYBR Green mix (Life Technologies/Applied Biosystems) and standard protocols. SYBR Green
primer sets for the murine cyclophilin, insulin-induced gene-1
(Insig-1), 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase
(Hmgcr/Hmdh), HMG CoA synthase (Hmgcs), farnesyl diphosphate synthase (Fdps), low density lipoprotein receptor (Ldlr),
stearoyl-CoA desaturase-1 (Scd1), and Scd2 genes have been
reported previously [19,20]. Additional primer sets for the murine
glyceraldehyde 3-phosphate dehydrogenase (Gapdh), fatty acid
desaturase-2 (Fads2), sterol-C4-methyl oxidase-like (Sc4mol), starrelated lipid transfer (START) domain containing 4 (Stard4),
proteoglycan 4 (Prg4), loricrin (Lor), and fibroblast growth factor
receptor 1 oncogene partner 2 (Fgfr1op2) genes were taken from
the MGH/Harvard Medical School primer bank (http://pga.
mgh.harvard.edu/primerbank/) and are given in Table S1. The
relative amount of all mRNAs was calculated using the
comparative Ct method with cyclophilin or Gapdh as the invariant
control.

Analysis of ER stress response in S1P

cko

Results
Retention of cartilage matrix proteins in the ER
Chondrocytes by nature are secretory cells and secrete large
amounts of ECM proteins needed to create the cartilage matrix.
Ultrastructural analysis of cartilage from S1Pcko mice showed an
enlarged ER with the retention of a crystalline material [15].
Therefore we first examined the composition of proteins retained
within the ER. Using double-labeled immunofluorescence, an
antibody to calnexin (an ER membrane protein) and an antibody
(IIF; see Table 1) against the Col II triple helical domain (THD),
we analyzed whether Col II in the mutant cartilage was trapped in
the ER (Fig. 1).

chondrocytes

RNA extracted from the chondroepiphysis of E16.5 WT and
S1Pcko embryos was used to further validate the unaffected UPR
discerned from the microarray analysis. For X-box binding
protein-1 (XBP-1) mRNA splicing assay, RNA was converted to
cDNA using routine protocols and splicing analyzed by PCR or by
restriction digestion. For PCR analysis, the cDNA was amplified
using XBP-1 primers as described [21] and the PCR products
directly analyzed in a 4.8% polyacrylamide gel to separate the
products derived from the spliced and un-spliced XBP-1 mRNA
PLOS ONE | www.plosone.org
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Figure 1. The ER retention of Col II in S1Pcko chondrocytes. (A–F) Double-labeled immunofluorescence analyses for Col II THD (IIF antibody)
and calnexin in E16.5 femurs in WT (A–C) and S1Pcko (D–F). Signals from calnexin (A, D) are shown in green (white arrows) and those from Col II THD
(B, E) are shown in red (white arrowheads) with composite signals shown in C and F. (G–L) Double-labeled immunofluorescence analyses for Col II
THD and XBP-1 in E16.5 femurs in WT (G–I) and S1Pcko (J-L). Individual signals from XBP-1 (G, J) are shown in green (white arrows) and those from Col
II THD (H, K) are shown in red (white arrowheads), with composite signals shown in I and L. All images shown are for mature columnar proliferative
chondrocytes in the WT and a corresponding region in S1Pcko (see Fig. S1A). Bar (all panels): 10 mm.
doi:10.1371/journal.pone.0105674.g001

II-derived matrix in the cartilage of the WT (Fig 1B, C). In S1Pcko
however, signaling from Col II THD (red) is visible primarily from
inside the cells (white arrowheads, Fig. 1E) concomitant with the
drastic drop of Col II-derived signals from the S1Pcko cartilage.
The chondrocytes appear distended from the entrapped Col II

In WT, the Col II THD in the cartilage (shown as red
immunofluorescence, white arrowheads, Fig. 1B, C) is distinct
from calnexin (shown as green immunofluorescence, Fig. 1A, C) of
the ER membrane surrounding the blue DAPI-stained nuclei of
the chondrocytes (Fig. 1A–C). Notice the strong presence of a Col
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does not resemble that seen in the WT cartilage and appears
disordered and filamentous. In fact, COMP distribution in S1Pcko
cartilage approximates the distribution of Col IIA (compare
Fig. 3E to 2K). This is probably due to the absence of the Col II
THD domain in the S1Pcko cartilage. Labeling S1Pcko cartilage for
both Col II (red) and COMP (green) (Fig. 3H) showed that COMP
and Col II occupy distinct domains. While most of Col II is
detected intracellularly, the majority of COMP is seen as a
network in the cartilage. While some COMP is also detected
trapped in the ER in S1Pcko chondrocytes (white arrows with
asterisk, Fig. 3E, H), these are usually very small aggregates and
are usually surrounded by the larger Col II aggregates (Fig. 3H)
suggesting retention due to a physical interaction with Col II (see
DISCUSSION). Moreover, this retention of COMP is insignificant when compared to pro-Col IIB retention and has no
consequence in the formation of a COMP matrix in the mutant
cartilage. Co-localization studies with aggrecan (Agc) show that
like COMP, S1P ablation does not affect its secretion (Fig. 3J).
Thus our studies demonstrate that pro-Col IIB is the primary
cartilage matrix protein trapped in the ER of S1Pcko chondrocytes.

protein. In the composite image (Fig. 1F), Col II is visible as
yellowish-orange immunofluorescence signal surrounding the
blue-DAPI-stained nuclei, due to its colocalization with calnexin
(white arrows, Fig. 1D, F) in the ER. To confirm the ERentrapment of Col II in the mutant, we analyzed whether Col II
colocalized with XBP-1 [25], a known ER luminal protein
(Fig. 1G–L) in S1Pcko cartilage. As shown in Fig. 1J-L, Col II
colocalized with XBP-1 in the mutant chondrocytes confirming its
entrapment in the ER. Even though results are shown for the
proliferative zone, Col II retention is seen throughout all zones of
the growth plate and is not limited by cell size, morphology or
location in the growth plate. These data indicate that the matrix in
S1Pcko cartilage is defective and devoid of Col II due to disruption
of Col II trafficking from ER to the cartilage.
During synthesis, Col II is made as a procollagen of three
identical pro-a-chains consisting of the amino (N) terminal
propeptide, the THD domain, and the carboxy (C) terminal
propeptide. The Col II protein incorporated into the mature
cartilage is the THD domain with the N- and C-terminal
propeptides removed. To understand the nature of the trapped
Col II, we performed double-labeled immunofluorescence with the
IIBN antibody [18], which detects the unique exon 1–3 peptide
junction sequence specific to type IIB procollagen (pro-Col IIB)
produced by chondrocytes (in contrast to the type IIA procollagen
made by chondroprogenitor cells), in combination with anticalnexin (Fig. 2A, B). In WT, signals from pro-Col IIB are
undetectable presumably due to a rapid processing of the
procollagen (Fig. 2A) [18]. In the composite picture for the WT
(pro-Col IIB + calnexin; Fig. 2A) only signals from calnexin are
seen showing the presence of the ER compartments. In contrast in
S1Pcko, significant signals from pro-Col IIB are detected that
overlaps with signals from calnexin inside the cell (Fig. 2B).
When we repeated the analysis for pro-Col IIB in combination
with IIF antibody (Fig. 2C–F), only the Col II THD is seen in the
WT cartilage matrix indicating the presence of the mature
processed Col II protein (Fig. 2C, E). However, hardly any Col II
THD is detected in the S1Pcko cartilage (Fig. 2D, F; also see
Fig.1E). Signals from Col II THD is seen primarily trapped inside
the cells (Fig. 2D) that overlaps with intracellular signals from proCol IIB (Fig. 2F). These observations indicate that in the mutant,
the pro-Col IIB isoform of Col II is trapped in the ER. In order to
analyze if this retention is specific to pro-Col IIB, we repeated the
analysis using the IIA antibody specific to type IIA procollagen
(Col IIA). In the WT (Fig. 2G–I), Col IIA is detected only outside
the cell in the cartilage ECM where it forms an organized lattice
network (in green, Fig. 2H). Importantly, an organized lattice
network specific to Col IIA is also seen in S1Pcko cartilage. The IIF
antibody as seen before did not identify any Col II network in the
mutant (compare Fig. 2I to 2L). These observations indicate that
the absence of S1P activity affects only pro-Col IIB trafficking
from the ER, and not Col IIA.
Next, we analyzed if trafficking of other major matrix proteins
such as COMP and aggrecan is affected in S1Pcko (Fig. 3). In WT
chondrocytes, COMP (in red) is visible in the cartilage (white
arrowheads, Fig. 3B, C) and its localization is distinct from
calnexin (in green, white arrows, Fig. 3A,C) which surrounds the
DAPI-stained blue nuclei. The distribution of COMP in the WT
cartilage matrix is similar to that of Col II (compare Fig. 3B to Fig.
1B or 2C, E). Therefore when we labeled both Col II THD (red)
and COMP (green) in the WT (Fig 3G), the staining patterns for
Col II and COMP overlapped in the matrix; the cartilage is seen
as yellowish-green in most areas with very little Col II or COMP
detected intracellularly. Interestingly, the S1Pcko cartilage also has
a COMP-derived matrix (Fig. 3E, F). But COMP distribution
PLOS ONE | www.plosone.org

Genome-wide expression profiling
The primary, well studied role of S1P is its transcription factor
processing activity. Lack of transcription factor processing by S1P
would affect both UPR and cholesterol/fatty acid homeostasis,
which could be causal to S1Pcko phenotypes. To understand the
mechanisms behind this phenotype we profiled gene expression in
mutant cartilage by microarray and contrasted it to WT cartilage
to identify the biological processes disrupted in S1Pcko chondrocytes. Statistically significant genes were identified by 2-way
ANOVA analysis coupled with FDR of 5% (only 5% genes
identified in the analysis could be false positive). Only genes that
were 2-fold or more differentially regulated in the mutant were
considered. Our primary aim was to understand the difference in
gene expression in the chondroepiphyseal cartilage which at
embryonic stages is the bulk of the cartilage in the skeletal
elements. While S1Pcko does not have any endochondral bone, it
does have an enhanced cortical bone. Therefore entire long bones
were also harvested and compared in this study. The Illumina
MouseWG-6 v1.1 Expression BeadChip used in this study was
chosen as it profiles more than 45,200 mouse transcripts including
probes derived from the Mouse Exonic Evidence Based Oligonucleotide set and some less-characterized genes/probe sets derived
from exemplar protein coding sequences from RIKEN FANTOM2.
A principal components analysis (PCA) scatter plot representing
only 40.8% of the whole genome information present in the
microarray hybridization signals demonstrated that very little
difference in gene expression is seen between the WT and S1Pcko
calvaria (Figure S1C). This suggested that skeletal structures
arising from intramembranous ossification were likely not as
affected by S1P ablation presumably because this developmental
pathway does not need a cartilage intermediate. The PCA analysis
also revealed that the largest difference in gene expression profile
between WT and S1Pcko lay in the cartilage. A 2-way ANOVA
analysis coupled with a minimum of +2 to -2 differential fold
regulation generated a stringent list of genes differentially
regulated in S1Pcko chondrocytes. Comparison of the gene
expression profile between WT and S1Pcko long bones showed
similar data (not shown) presumably due to the presence of RNA
from the cartilage, indicating that the difference lay primarily in
the cartilage. Incorporation of calvaria data set in these analyses
did not make any difference to the differentially expressed genes
identified. Tables S3 and S4 list genes that are significantly
5
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Figure 2. Specific retention of pro-Col IIB in S1Pcko chondrocytes. Double-labeled immunofluorescence analyses were done for pro-Col IIB
(red, IIBN antibody) and calnexin (green) in E16.5 femurs in WT (A) and S1Pcko (B) and only the composite for this analysis is shown. In a separate
analysis (symbolized by the dashed line between panels A/B and C/D), double-labeled immunofluorescence was done for Col II THD (red) (C–F) and
pro-Col IIB (green) (E, F) in E16.5 femurs in WT (C, E) and S1Pcko (D, F) with composite signals shown in E and F. Panels G-L show double-labeled
immunofluorescence analyses for Col II THD (red) (G, J) and Col IIA (green; IIA antibody) (H, K) in E16.5 femurs in WT (G–I) and S1Pcko (J–L).
Composite signals are shown in panels I and L. All images shown are for mature columnar proliferative chondrocytes in the WT and a corresponding
region in S1Pcko. Bar (all panels): 10 mm.
doi:10.1371/journal.pone.0105674.g002

tially regulated (as per their p values) and exhibit fold changes of 2 or
more. Figure 4B shows the range of differential regulation in S1Pcko
chondrocytes and the identity of some critical genes.

differentially regulated (up- or down-regulated, respectively) in
S1Pcko chondrocytes. Figure 4A shows a volcano plot of the
ANOVA analysis representing genes that are significantly differen-
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Figure 3. COMP and aggrecan are not intracellularly retained in S1Pcko chondrocytes. Double-labeled immunofluorescence analyses for
COMP and calnexin in E16.5 femurs in WT (A–C) and S1Pcko (D–F). Individual signals from calnexin (A, D) are shown in green (white arrows) and those
from COMP (B, E) are shown in red (white arrowheads), with composite signals in C, F. The relative distribution of Col II THD (red) and COMP (green)
proteins for WT (G) and S1Pcko (H) are shown as composites from double-labeled immunolabeling analyses in E16.5 femurs. Occasional entrapment of
COMP is indicated by arrows marked with an asterisk. Composite signals showing the localization of aggrecan (Agc) (red) relative to calnexin (green)
in E16.5 WT (I) or S1Pcko (J) femurs. All images shown are for mature columnar proliferative chondrocytes in the WT and a corresponding region in
S1Pcko. Bar (all panels): 10 mm.
doi:10.1371/journal.pone.0105674.g003

Analyses of differentially expressed genes to identify functional
biological pathways disrupted in the cartilage due to S1P ablation
were done by GeneGo (MetaCore). Surprisingly, this analysis
showed that the top 10 processes upregulated in S1Pcko belonged
PLOS ONE | www.plosone.org

primarily to UPR pathways (Fig.5A). This suggested that ER stress
response pathways were unaffected in S1Pcko cartilage. Furthermore, when a functional molecular network was created with these
up-regulated genes with the addition of ATF6a to the network
7
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Figure 4. (A) A volcanic plot of the 145 differentially regulated genes in the S1Pcko cartilage identified by 2-way ANOVA analysis. Only genes that
show at least a 2-fold differential regulation with a p,0.05 (FDR #0.05) are shown, with the color red and its gradations identifying up-regulated
genes and the color blue and its gradations identifying down-regulated genes. (B) Schematic representation of critical genes up- or down-regulated
in S1Pcko chondrocytes as compared to WT showing the range of differential expression in the mutant (un-abbreviated gene names are listed in
Tables S3 and S4).
doi:10.1371/journal.pone.0105674.g004
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Figure 5. (A) A schematic representation of the top ten biological pathways up-regulated in S1Pcko chondrocytes identified by GeneGo (MetaCore)
based on their p value. The majority of up-regulated pathways belong to UPR in response to ER stress. (B) A molecular network generated from
upregulated genes with the addition of ATF6a to the network. Green lines represent activation and red lines represent inhibition.
doi:10.1371/journal.pone.0105674.g005

S1Pcko chondrocytes. This suggested that ATF6 activity was
unlikely to be disrupted in S1Pcko. When the significantly
differentially down-regulated genes were analyzed similarly by

(Fig. 5B), a number of genes were found to be connected to
ATF6a, directly or indirectly, and also to each other, acting in
concert to respond to ER stress due to pro-Col IIB entrapment in
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Figure 6. (A) A schematic representation of the top ten biological pathways down-regulated in S1Pcko chondrocytes as identified by GeneGo based
on their p value. The majority of down-regulated pathways identified belong to cholesterol and lipid biosynthetic pathways. (B) A molecular network
generated from down-regulated genes with the addition of SREBPs to the network. Green lines represent activation and red lines represent
inhibition.
doi:10.1371/journal.pone.0105674.g006

GeneGo, the top 10 down-regulated processes belonged primarily
to cholesterol and lipid biosynthetic pathways (Fig. 6A). As with
the up-regulated genes, when a molecular network was created
with the down-regulated genes with the addition of SREBPs to the
network, a large number of these genes were found to be
PLOS ONE | www.plosone.org

interconnected with SREBP-1 and SREBP-2 (Fig. 6B) indicating
that this is not an isolated event but are molecular events acting in
concert to down-regulate cholesterol and lipid biosynthesis.
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Figure 7. Intact ER stress response in S1Pcko chondrocytes. (A) RNA from the chondroepiphyseal cartilage of E16.5 WT (lane 1) and S1Pcko (lane
2) used in microarray analysis were converted to cDNA and amplified by XBP-1 PCR primers to identify spliced (s) XBP-1 mRNA in a 4.8%
polyacrylamide gel. (B) XBP-1 was amplified by PCR using XBP-1 PCR primers 3S and 12AS with cDNA derived from E16.5 WT (lanes 1, 3, 5) and S1Pcko
(lanes 2, 4, 6) epiphyseal cartilage RNA and the PCR product restriction digested with PstI which selectively cuts the un-spliced (u) XBP-1 mRNA, and
the resulting products visualized in a 2% agarose gel. In lanes 1 and 2, the cDNA used are from the same embryos used in (A) and for genome-wide
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expression profiling. Each lane in lanes 3–6 show analyses from RNA pooled from the chondroepiphysis of two different embryos. Thus a total of five
WT and five S1Pcko embryos were analyzed. The inverse of the gels are shown in both (A) and (B) to enhance visualization of spliced XBP-1 mRNA. (C–
F) Expression signaling for two ATF6-driven genes, BiP and Sdf2l1, as seen by in situ hybridization analyses in WT and S1Pcko cartilage. BiP expression
is seen in the ulna, carpal, and metacarpal regions in E16.5 WT (C) and S1Pcko (D) forelimbs. Sdf2l1 expression is seen in the femur of E15.5 WT (E) and
S1Pcko (F). Bar: 10 mm. (G) A scatter plot generated from quantitative real-time PCR analysis in the murine UPR RT2 Profiler PCR Array system
comparing the relative expression of 84 genes between WT and S1Pcko chondrocytes. A log transformation plot is shown in which the relative gene
expression level of each gene (2-DCt) in WT is plotted against the corresponding value in S1Pcko to indicate fold changes (2-DDCt). The black line
indicates no fold change (fold change of 1). The pink lines indicate a fold change of 2 (gene expression threshold). All genes within these two lines are
considered to be similar in expression to WT. Only Ddit3 or Insig-1 were significantly differentially expressed among the 84 genes profiled. A total of
four WT and four S1Pcko embryos were profiled.
doi:10.1371/journal.pone.0105674.g007

Intact unfolded protein response in S1Pcko chondrocytes

We also confirmed XBP-1 splicing by coupling restriction
digestion with PCR by using primers 3S and 12AS [22] on cDNA
derived from the chondroepiphyseal cartilage RNA of more than
one E16.5 WT and S1Pcko embryo (Fig. 7B). Again, both WT and
S1Pcko showed the ability to splice XBP-1 mRNA suggesting an
intact IRE-1 directed UPR system in the mutant chondrocytes.
Based on microarray analysis, we did not observe any downregulation of any known ATF6-responsive genes during ER stress
response. Genes whose expressions are driven by ATF6 such as
glucose related protein 78 (Grp78/BiP/Hspa5), heat shock protein
90b1 (Hsp90b1/Grp94), derlin-3, and stromal cell-derived factor
2-like 1 (Sdf2l1), and are significantly down-regulated during ER
stress induction in ATF62/2 cell lines [37] were not identified as
differentially regulated in S1Pcko cartilage. To confirm this
observation we performed in situ hybridization analysis for Sdf2l1
and BiP. Significant expression of these genes was detected in
S1Pcko cartilage (Fig. 7D, F). In order to validate the microarray
results and to get a definitive, global answer about ER stress
response we performed qPCR analysis by using the murine
Unfolded Protein Response RT2 Profiler PCR Array system that
profiles the expression of 84 genes (Table S2) involved in
recognizing and responding to misfolded protein accumulation
in the ER (Fig. 7G). For this assay we used fresh RNA isolated
from the chondroepiphysis of four WT and four S1Pcko E16.5
embryos allowing for biological duplicates. Only two significant
deviations from WT cartilage was observed, namely Ddit3 and
Insig-1, which were also identified from microarray studies
(Fig. 4B). The rest of the genes profiled including genes such as
BiP (Hspa5), Herp, and Edem1, whose expressions were downregulated on ER stress in ATF62/2 cell lines, did not show any
significant change in the mutant. These observations confirmed
normal UPR responses in S1Pcko.

The UPR is modulated by the action of three distinct pathways
via three distinct ER transmembrane sensors, IRE1 (inositolrequiring transmembrane kinase and endonuclease 1), PERK
(protein kinase-like ER kinase), and ATF6 [26–28]. Activation of
IRE1 results in the endonucleolytic cleavage of XBP-1 mRNA to
allow for frame-shift translation and expression of the active XBP1 transcription factor, which increases the expression of UPRresponsive genes. Activation of PERK pathway leads to phosphorylation of elongation initiation factor 2a thereby inactivating
it, which attenuates translation thus decreasing the protein burden
of the cell. Furthermore, this diminished translation allows for the
selective increased translation of ATF4 which alone or in
combination with XBP-1 allows for expression of UPR-responsive
genes. Release of ATF6 from the ER by the combined action of
S1P and site-2 protease (S2P) and its translocation to the nucleus,
in cooperation with NF-Y or XBP-1, up-regulates transcription of
UPR-responsive genes.
An indication that the PERK pathway is normal in S1Pcko is
seen by the up-regulation of ATF4 identified in the microarray
analysis (Fig. 4B, 5B). This is further confirmed by the increased
expression of ATF4-controlled genes such as DNA damage
inducible transcript 3 (Ddit3, also known as C/EBP zeta/
CHOP/CHOP10; Fig. 4B, 5B) [29]. Ddit3 is known to be
involved in a variety of ER stress response pathways [30,31]. It is
also known to induce apoptosis in response to ER stress [32]. This
up-regulation is in consensus with the drastic increase in apoptosis
seen in S1Pcko cartilage [15]. ATF4 also up-regulates genes
involved in amino acid metabolism that may protect against
oxidative stress by promoting glutathione synthesis. The microarray analysis also showed increased expression of two well known
markers of this response, the amino acid transporter protein solute
carrier family 7 (Slc7a3) and the amino acid biosynthetic enzyme
asparagine synthetase (Asns) (Fig. 4B and 5B) [33,34]. Upregulation of several aminoacyl tRNA synthetases such as seryl
amino-acyl tRNA synthetase (Sars) and alanyl tRNA synthetase
(Aars) is also seen (Fig. 4B). Advanced ER stress response is also
indicated by another target of ATF4-CHOP, namely tribbles 3
(Trib3/Nipk) (Fig. 4B, 5B), an ER stress inducible gene, which
also functions by down-regulating its own induction to attenuate
CHOP and ATF4 mediated transcriptional events [35]. Induction
of the cell cycle inhibitor p21 (Cdkn1a) (Fig. 4B, 5B), a negative
regulator of apoptosis [36] could be the cell’s attempt to
antagonize increased apoptosis.
To analyze events directed by the IRE1 pathway we analyzed
XBP-1 splicing in S1Pcko chondrocytes (Fig. 7A, B). Using XBP-1
primers whose sequences are common to both the spliced (s) and
un-spliced (u) XBP-1 mRNA [21,25] we checked the ability of the
primers to generate the smaller, spliced XBP-1 mRNA product in
PCR reactions using cDNA made from WT and S1Pcko RNA used
in the genome-wide expression profiling (Fig. 7A). Both WT and
S1Pcko cDNA showed the ability to generate the s-XBP-1 mRNA.
PLOS ONE | www.plosone.org

Down-regulation of SREBPs-responsive genes in S1Pcko
cartilage
Figure 6 suggested that genes/pathways regulated by SREBPs
involved in cholesterol and fatty acid biosynthetic processes are
primarily down-regulated in S1Pcko cartilage. In order to confirm
this observation we performed qPCR analyses of a number of
genes identified as down-regulated (see Table S4). A number of
these are known to be direct targets of S1P/SREBP regulatory
pathway, i.e. genes reported to have a sterol regulatory element
(SRE) motif in their promoter and requiring SREBPs as
transcription factors for their synthesis [38] (see Fig. 4B, 6B). As
with the qPCR-based global UPR analyses above, we used fresh
RNA pooled from the chondroepiphysis of five E16.5 WT or five
S1Pcko embryos. A number of genes identified as down-regulated
by microarray analysis such as Fgfr1op2, Sparc, and Loricrin did
not show down-regulation in mutant chondrocytes on qPCR
analysis (not shown). Along with Prg4 (which is not reported to use
SREBPs as transcription factors for its expression; see DISCUSSION), qPCR analyses confirmed that genes such as Scd1,
12
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Discussion

Table 2. Quantitative real-time PCR analyses of genes downregulated in S1Pcko chondrocytes when compared to WT
littermates.

Gene

Wild Type

S1Pcko

Scd1

1.00

0.27

Sc4mol

1.00

0.41

Fads2

1.00

0.54

Scd2

1.00

0.57

Stard4

1.00

0.58

Ldlr

1.00

0.59

Insig-1

1.00

0.63

Fdps

1.00

0.65

Hmgcs

1.00

0.86

Hmgcr

1.00

0.91

The disruption of Col II secretion is central to S1P ablations
[15,41]. In this study we demonstrated that S1P ablation in
cartilage results in the specific retention of the pro-Col IIB isoform
in the chondrocyte ER. As the Col2-Cre system initiates deletion
of S1P very early at E11.5-E12 [42], chondroprogenitor cells
which synthesize Col IIA also suffer from S1P ablation. However
this has no effect on Col IIA secretion, a difference probably
mediated by the presence of exon 2 coded sequences in the Npropeptide of Col IIA. Thus, pro-Col IIB is the major cartilage
protein retained in mutant chondrocytes which prevents the
formation of a Col II matrix in S1Pcko cartilage. This indicates that
S1P ablation disrupts pro-Col IIB trafficking from the ER and that
a S1P-derived activity is essential for pro-Col IIB trafficking from
the ER to the cartilage. The minor retention of COMP is
presumably due to interactions between small amounts of COMP
with the large pro-Col IIB aggregates in the ER. This phenomenon is not unique to S1Pcko and has been observed in
pseudoachondroplasia (PSACH) chondrocytes. PSACH chondrocytes express mutant COMP which causes its retention in the ER.
Interactions between the trapped mutant COMP and Col II
results in matrix formation inside the ER [43] with Col II
aggregates surrounded by a COMP matrix. These observations
indicate that the minor retention of COMP seen in S1Pcko
cartilage is incidental to pro-Col IIB retention. The dynamic
association between Col II and COMP in the cartilage is also
evidenced by the similarity and overlap of their distribution in WT
cartilage and the absence of a similar COMP organization in
S1Pcko cartilage due to the lack of a pro-Col IIB-derived Col II
matrix.
In order to identify the molecular pathways affected by S1P
ablation that disrupted pro-Col IIB trafficking, we performed
genome-wide expression analysis in the S1Pcko model. Genomewide expression profiling on RNA isolated from the chondroepiphyseal cartilage of E16.5 S1Pcko and WT littermates followed by
2-way ANOVA and gene ontology enrichment analysis demonstrated that only the SREBPs-regulated pathways are affected in
S1Pcko chondrocytes. The Prg4 (lubricin) gene which has no
reported association with S1P or SREBPs or any SRE motif in its
promoter was also found to be down-regulated. However,
knockout mouse models for Prg4 [44] do not show any defects
in endochondral bone formation or Col II trafficking to the ECM.
Therefore, it seems possible that Prg4 down-regulation in S1Pcko
cartilage is a secondary effect due to poor cartilage matrix
development in these mice or due to abnormal chondrocyte
differentiation.
As chondrocytes secrete large amounts of various cartilage
matrix proteins to assemble the specialized cartilage ECM, a
functional UPR would be indispensable to this function. Thus we
had hypothesized that S1P ablation would prevent an effective
UPR response to ER stress which would cause intracellular Col II
accumulation [15]. However, UPR response pathways are
unaffected in S1Pcko chondrocytes. The activity of ATF6 is
unchanged on S1P ablation and there is a lack of differential
expression of ATF6-responsive genes such as BiP and Sdf2l1. This
can be explained by reasoning that the requirement of S1P for
ATF6 processing is not absolute, which is also noted in other
systems. ER stress response was reported to be normal in zebrafish
gonzo phenotype where expression of BiP was shown as unaltered
in absence of S1P [6]. The S1P-lacking SRD-12B cells demonstrated only a partial ability to prevent ATF6 processing to its

RNA was harvested and pooled from the chondroepiphyseal cartilage of five
E16.5 S1Pcko or five E16.5 WT embryos.
doi:10.1371/journal.pone.0105674.t002

Sc4mol, Fads2, Scd2, Stard4, Ldlr, Insig-1, and Fdps, which are
direct targets of SREBPs and involved in the cholesterol/lipid
biosynthetic pathways, are down-regulated in S1Pcko cartilage
(Table 2) mirroring that seen in the microarray. Especially
significant among these genes was Scd1 which exhibited the
largest down-regulation. We further validated these observations
by in situ hybridization analysis demonstrating the downregulation of Scd1, Scd2, Ldlr, Fads2, and Fdps genes at the
RNA level in the humerus of S1Pcko mice (Fig. 8). Immunohistochemistry also confirmed the down-regulation of the Scd1
protein in the distal femoral cartilage in S1Pcko mice (Fig. 8). These
analyses confirmed the significant down-regulation of cholesterol
and fatty acid biosynthetic pathways in the mutant and suggested
that this down-regulation may be causal to the abnormal cartilage
ECM and lack of endochondral bone development.
To follow this observation further, we studied Col II retention
and endochondral bone formation in Scd1 knockout (Scd12/2)
mice. Among genes with a direct molecular link to SREBPs, the
Scd1 gene was maximally down-regulated and thus could be
considered a good candidate to induce the S1Pcko phenotypes.
Scd1 enzyme catalyzes the D9-desaturation of saturated fatty acids
such as palmitic acid and stearic acid to their corresponding
monounsaturated fatty acids (MUFA), palmitoleate and oleate,
respectively. As membranes are composed of lipids, we hypothesized that retention of matrix proteins in the ER and the resulting
ER stress could be due to ER membrane lipid changes. Changes in
MUFA composition of the ER membrane and the resulting
changes in membrane fluidity could result in Col II retention in
the ER. To understand whether the phenotype in S1Pcko mice is
driven by lack of Scd1 activity, we analyzed endochondral bone
formation and Col II deposition in Scd12/2 mice. Scd12/2
mice not only suffer from the down-regulation of Scd1 activity but
also demonstrated down-regulation in lipid biosynthesis
[22,39,40], a situation that could be considered analogous to the
down-regulation of cholesterol and lipid homeostasis seen in
S1Pcko chondrocytes. Interestingly however, onset of endochondral
bone formation and Col II deposition in Scd12/2 mice were
similar to that seen in wild type (Scd1+/+) mice (Fig. 9).

PLOS ONE | www.plosone.org

13

August 2014 | Volume 9 | Issue 8 | e105674

ER Retention of Type IIB Procollagen in S1Pcko

Figure 8. Expression analyses of some key genes involved in cholesterol and fatty acid biosynthesis in S1Pcko cartilage by in situ
hybridization. Notice the drastic reduction in the expression of Scd1, Scd2, Ldlr, Fads2, and Fdps genes at the RNA level, shown by in situ
hybridization in S1Pcko humerus and by immunohistochemistry (IHC) for Scd1 protein in S1Pcko femur. All analyses are shown at E15.5 except for Fdps
which is shown at E14.5. Bars: (in situ hybridization analyses): 500 mm; (IHC): 200 mm.
doi:10.1371/journal.pone.0105674.g008

active form on induction of ER stress; only S2P ablation allowed
for a complete lack of ATF6 processing [45]. Thus, even moderate
amounts of active ATF6 in concert with other nuclear factors such
as NF-Y [30] and/or XBP-1 [46] would have sufficient
transcriptional induction properties to induce UPR. Thus, in this
study it was not possible to address the importance of UPR to
cartilage ECM development. However, viable and fertile ATF6a

PLOS ONE | www.plosone.org

knockout mice were reported [46] suggesting that ATF6-directed
ER stress responses are not necessary for normal Col II deposition
or endochondral bone development in mice. Notably, these studies
indicate that the apoptosis seen in S1Pcko cartilage is due to the
trapped Col II in the ER and induction of UPR, rather than an
inability to respond to ER stress.
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processing [45,50]. This would explain the specific downregulation of SREBP-driven pathways in S1Pcko chondrocytes.
However, this down-regulation does not appear to be responsible
for the mutant phenotypes seen on S1P ablation in chondrocytes.
We had surmised that potential changes in ER membrane
composition and fluidity accompanying the down-regulation of
sterol and lipid pathways may be responsible for Col II retention
seen in the ER. If this was true then these ER membrane changes
would also be present in the chondrocyte ER of Scd12/2 mice
that would lead to abnormal cartilage and endochondral bone
development. However, we observed no intracellular Col II
retention or lack of endochondral bone development in Scd12/2
mice. It is also striking that mice lacking Ldlr [51,52] or Fads2
(Delta-6 desaturase) [53], genes that are also down-regulated in
S1Pcko chondrocytes, show no disruption in endochondral bone
development as that seen in S1Pcko. Furthermore, neither are these
mutant phenotypes seen in mouse models with compound or
multiple disruptions in lipid homeostasis such as Ldlr2/2;Lcat2/
2 mice [51].
These observations may be explained by the possibility to
separate cartilage developmental pathways from lipid pathways. In
the zebrafish gonzo phenotype, S1P ablation results in both
cartilage and lipid phenotypes. But ablation of SREBP cleavageactivating protein (SCAP) results only in lipid phenotypes but no
cartilage phenotype [6]. This indicates that lipid and cartilage
defects are caused by different mechanisms. However, it has been
reported that the inhibition of cholesterol biosynthesis through the
administration of a chemical inhibitor AY 9944 in mice suppressed
longitudinal bone growth via suppression of chondrocyte proliferation and hypertrophy [54]. These contrasting observations
make it difficult to discern the exact mechanistic input of sterol and
lipid homeostasis to cartilage development. It is possible that
cholesterol/lipid down-regulation and ER entrapment of Col II
are independent phenotypes from two separate functions of S1P,
but those functions relating to Col II trafficking remain to be
identified.
Figure 10 summarizes our current findings. In this study we
investigated all current known functions of S1P: induction of ER
stress response, induction of cholesterol and fatty acid biosynthesis,
processing of BBF2H7 to effect Sec23a expression, and the
processing of the a/b subunit precursor of N-acetylglucosamine-1phosphotransferase complex (GNPTAB). Recently it was demonstrated that GNPTAB, involved in the addition of mannose 6phosphate residues on lysosomal enzymes, is a direct S1P substrate
[55]. In our preliminary experiments, there is at least equivalent
GNPTAB a/b precursor cleavage activity in S1Pcko chondrocytes
as in chondrocytes from its wild type littermates (not shown). This
indicates that this activity is not lost in S1Pcko chondrocytes and
therefore not causal to the mutant phenotypes. Besides, mucolipidosis II (Gnptabc.3082insC) mice (which lack GNPTAB) do not
exhibit lack of endochondral bone formation or Col II entrapment
in the ER [55]. Our studies thus indicate that activities associated
with current known functions of S1P cannot provide for a direct
molecular explanation of S1Pcko phenotypes, especially the
entrapment of pro-Col IIB in the ER. We therefore propose that
S1P has additional, novel substrates in chondrocytes (schematized
in Fig. 10), likely non-transcription factor-related, that is vital to
normal cartilage development; at least one of these substrates is
specific and indispensable for pro-Col IIB processing and/or
trafficking from the ER. The identification of this novel S1P
substrate will not only allow for a molecular understanding of

Figure 9. Normal endochondral bone development and Col II
deposition in Scd12/2 mice. (A, B) Sections of E15.5 humerus were
stained with Safranin O, Fast green, and hematoxylin showing normal
onset of endochondral bone development in Scd12/2 mice. (C–F)
Double-labeled immunofluorescence analyzing Col II deposition in
Scd12/2 mice using IIF and IIA antibodies. Colors represent antibody
localizations as follows: green, Col IIA (IIA antibody); red, Col II THD (IIF
antibody); yellow, colocalization of both antibodies; blue, DAPI-stained
nuclei. Panels C and D show the matrix around early immature
chondrocytes in the resting zone; panels E and F show the matrix
around mature columnar chondrocytes in the proliferative zone. Bar: (A,
B): 500 mm; (C–F): 50 mm.
doi:10.1371/journal.pone.0105674.g009

Other ER stress transducers such as OASIS and its related
family members BBF2H7 and CREBH also appear to be
unaffected. OASIS has a specific expression pattern and is
primarily induced in bone tissues and the central nervous system,
but no expression in chondrocytes has been reported [47]; likewise
CREBH is liver-specific [5]. Thus OASIS and CREBH and their
dependent pathways are not relevant in S1Pcko. But BBF2H7
differs from OASIS in its strong expression in the proliferating
zone of the cartilage [48]; it has also been reported to need S1P for
its processing [49] and would be expected to be inactive in S1Pcko
chondrocytes. Bbf2h7-/- mice show severe chondrodysplasia and
the retention of Col II in the ER similar to that seen in S1Pcko mice
[48]. BBF2H7 is required for the expression of Sec23a protein, a
component of COPII vesicles which transports secretory proteins
from ER to the matrix. However, Sec23a is unaffected in S1Pcko
chondrocytes as it was not identified as differentially downregulated in the microarray analysis and was further validated by
qPCR analysis (Figure S2); nor were its protein levels affected (not
shown). Therefore, in S1Pcko chondrocytes, ER stress transducers
and their activities have remained largely unaffected.
However the requirement for S1P is absolute for the SREBPs.
SRD-12B (S1P2/2) cells, which only partially prevent ATF6
processing, are able to impose a complete block of SREBPs
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Figure 10. A schematic summarizing the results from this study and possible additional roles for S1P in cartilage development. S1P
is historically known for processing the transcription factors ATF6 and SREBPs. Two relatively recently discovered activities include the processing of
BBF2H7 and the a/b subunit precursor of N-acetylglucosamine-1-phosphotransferase complex (GNPTAB). Of these four known activities, only SREBPs
activities relating to cholesterol and fatty acid homeostasis are down-regulated in S1Pcko chondrocytes, with maximal down-regulation of Scd1.
However this does not appear to be responsible for the S1Pcko mutant phenotypes as pro-Col IIB retention in chondrocytes or lack of endochondral
bone development is not seen in Scd12/2 mice. The retention of pro-Col IIB in the ER could be due to changes in ER membrane lipid composition,
though unlikely as pro-Col IIB retention is not seen in Scd12/2 mice. Processing of additional, yet unidentified, S1P substrates in chondrocytes likely
modulate pro-Col IIB trafficking from the ER. Lack of endochondral bone formation is probably due to the abnormal cartilage matrix devoid of Col II,
or due to unidentified S1P-regulated processes. In the figure, blue arrows indicate activities that are normal in S1Pcko chondrocytes; red arrows
indicate activities that are down-regulated or abnormal in S1Pcko. Dashed arrows with a question mark indicate the possibility of these mechanisms
directed by novel S1P substrates, but nothing more is known as yet.
doi:10.1371/journal.pone.0105674.g010

S1Pcko phenotypes, but will also allow for an unraveling of the
molecular mechanism involved in pro-Col IIB trafficking, a
phenomenon that still remains poorly understood. Our studies
thus indicate an increased breadth of S1P functions in chondrocytes mandatory for normal cartilage development.

separated from the bone. (C) A schematic representation of the
differences between WT (rectangles) or S1Pcko (triangles) RNA
using a principal component analysis scatter plot based on
microarray hybridization signals. RNA was analyzed from
cartilage (green), entire long bones (red), and calvaria (blue).
Differential gene expression between WT and S1Pcko calvaria
(blue) is minimal (located very close to each other). Differential
gene expression between WT and S1Pcko cartilage (green) is
maximum (located farthest from each other), while those between
WT and S1Pcko long bones (red) is intermediate to cartilage and
calvaria.
(EPS)

Supporting Information
Figure S1 (A) A diagrammatic representation of the WT
embryonic growth plate. All immunohistochemical analyses
are shown for the columnar proliferative regions above the
hypertrophic cells and for a corresponding region in S1Pcko. The
chondroosseous junction is the approximate region where the tips
of long bones were broken off and harvested for cartilage analysis
by microarray. S1Pcko lacks endochondral bone and the diaphysis
of the bone is cartilaginous. (B) A diagrammatic representation of
the cartilage tissue harvested for microarray analysis. For analysis
of WT and S1Pcko cartilage by microarray, the tips of the long
bones (shown demarcated by the dashed line and denoted as
epiphyseal cartilage) were broken off and stored in Trizol. When
entire long bones were harvested for analysis, the bones were
harvested intact and the epiphyseal cartilage portions were not

PLOS ONE | www.plosone.org

Figure S2 Expression levels for Sec23a are unaffected in

S1Pcko mice. Each WT or S1Pcko (CKO) analysis used RNA
pooled from the chondroepiphyseal cartilage of two embryos.
Thus a total of four WT and four S1Pcko embryos were analyzed.
Q-PCR analysis was done using the 2-DDCt method where the WT
values were set to one.
(EPS)
Table S1 SYBR Green qPCR primer sets for the murine
genes listed were taken from the MGH/Harvard
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Medical School primer bank (http://pga.mgh.harvard.
edu/primerbank/).
(DOCX)

that belong to fatty acid and cholesterol biosynthesis pathways.
RNAs with no corresponding gene names are not included in this
list.
(DOCX)

Table S2 A complete list of 84 genes that were profiled
by qPCR using the murine Unfolded Protein Response
RT2 Profiler PCR Array system, shown grouped according to their functions.
(DOCX)
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